Effect of melphalan dose adjustment in multiple myeloma patients undergoing autologous stem cell transplantation

被引：0
|
作者：
Gonzalez, A. P. [1 ]
Gonzalez, A. J. [1 ]
Palomo, P. [1 ]
Fernandez, R. [1 ]
Pardo, C. [1 ]
Alarcon, C. [1 ]
Fonseca, A. [1 ]
Fonseca, A. [1 ]
Gonzalez, S. [1 ]
Rayon, C. [1 ]
Vallejo, C. [1 ]
机构：
[1] Univ Cent Hosp Asturias, Oviedo, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 50 条
  • [1] The effect of melphalan administration time on engraftment in multiple myeloma patients undergoing autologous stem cell transplantation
    Unal, Ali
    Yildizhan, Esra
    Kaynar, Leylagul
    Varal, Fatma
    Ciftci, Sibel
    Coskun, Elmas
    Yildiz, Gulseren
    Yanar, Ayse
    Eser, Bulent
    Cetin, Mustafa
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 293
  • [2] Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma
    Buadi, Francis K.
    Gertz, Morie A.
    Laplant, Betsy R.
    Halvorson, Alese
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Dingli, David
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Miceli, Teresa
    Brandes, Eva
    Stafford, Scott L.
    Martenson, James A.
    Hogan, William J.
    Kumar, Shaji K.
    BLOOD, 2016, 128 (22)
  • [3] Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
    Srour, Samer A.
    Milton, Denai R.
    Bashir, Qaiser
    Nieto, Yago
    Saini, Neeraj
    Daher, May
    Ramdial, Jeremy
    Im, Jin
    Hosing, Chitra
    Delgado, Ruby
    Manasanch, Elisabet
    Lee, Hans C.
    Thomas, Sheeba
    Kaufman, Gregory
    Patel, Krina
    Popat, Uday
    Weber, Donna
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    HAEMATOLOGICA, 2021, 106 (12) : 3211 - 3214
  • [4] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [5] The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning
    Ursu, Sorana G.
    Maples, Samantha
    Williams, Kiersten J.
    Patrus, Gina
    Samhouri, Yazan
    Fazal, Salman
    Mewawalla, Prerna
    Sadashiv, Santhosh
    JOURNAL OF HEMATOLOGY, 2023, 12 (05) : 201 - 207
  • [6] Single daily dose of intravenous busulfan and melphalan as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J.
    Gonzalez, J.
    Solano, C.
    Rivas, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S323 - S323
  • [7] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [8] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [9] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH DOSE MELPHALAN IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT.
    Cho, Y.
    Wang, J.
    Gao, Y.
    Li, J.
    Lamprecht, M.
    Jukich, M.
    Schaaf, L. J.
    Poi, M.
    Hofmeister, C. C.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S38 - S38
  • [10] Bortezomib and Melphalan (Bor/MEL) Conditioning for Patients with Multiple Myeloma Undergoing Single Autologous Stem Cell Transplantation
    Zepeda, Victor H. Jimenez
    Duggan, Peter
    Neri, Paola E.
    Bahlis, Nizar J.
    BLOOD, 2014, 124 (21)
12345